Live tape
Top 8, mentions 7d7,001META1,798 mentions▲ +0.06GOOGL1,445 mentions▲ +0.03NVDA889 mentions▲ +0.09TSLA657 mentions▲ +0.05MSFT585 mentions▲ +0.06SPY572 mentions▲ +0.03AMZN555 mentions▲ +0.04AAPL500 mentions▲ +0.07

Equity · Consumer Defensive

NUS

NYSE

Nu Skin Enterprises, Inc.

$4.74 +2.16% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Aug 21, 2026
Price · Chart
Our own end-of-day closes 36 sessions
$6.0 $4.5 2 Jul 21 Aug

The line runs $5.02 on 2 July through $4.74 on 21 August, on a scale from $4.5 to $6.0. Days the market did not trade hold the previous close, flat.

The chart above plots the price of NUS over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 36 sessions over that window: $5.02 on 2 July 2026 through $4.74 on 21 August 2026.

Market cap $230.7M
52-week range $4.64 – $13
Avg volume 120.3K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Aug 21, 2026

NUS insider trades

SEC Form 4 · last 90 days · newest Form 4 filing 9 Sep 2026
Open-market buys 0
Open-market sells 0
Non-trade filings 1

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
09 Sep 2026 WOODBURY EDWINA D Director Award 22 $0K

NUS reported financials

SEC EDGAR XBRL

NUS reported revenue of $1.5B for the fiscal year ended 31 Dec 2025. Net income over the same period was $160.2M.

Figure Reported Period
Revenue $1.5B 31 Dec 2025 fiscal year
Net income $160.2M 31 Dec 2025 fiscal year
Diluted EPS $3.18 31 Dec 2025 fiscal year
Total assets $1.1B 30 Jun 2026 at period end
Total equity $542.7M 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

NUS earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $-5.14 —
31 Mar 2026 Q1 2026 $0.04 —
31 Dec 2025 FY 2025 $3.18 —
30 Sep 2025 Q3 2025 $0.34 —
30 Jun 2025 Q2 2025 $0.43 —
31 Mar 2025 Q1 2025 $2.14 —
31 Dec 2024 FY 2024 $-2.95 —
30 Sep 2024 Q3 2024 $0.17 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

NUS institutional holders

SEC Form 13F

5 of the 45 institutional funds we track reported a NUS position for the quarter ended 30 Jun 2026 — a combined $24.1M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Renaissance Technologies Held (±25%) −5.5% shares 1,607,692 $8.5M
Two Sigma Investments Held (±25%) +15.5% shares 1,168,634 $6.2M
AQR Capital Management Trimmed −36.2% shares 789,131 $4.0M
Citadel Advisors Added +187.9% shares 654,577 $3.5M
D. E. Shaw & Co. Held (±25%) −14.3% shares 380,690 $2.0M
Man Group Exited

Source: SEC EDGAR 13F filings

NUS fails-to-deliver

SEC CNS data

On 04 Sep 2026, 82 shares of NUS failed to deliver (about $385).

Settlement date Shares failed Notional % of shares out
04 Sep 2026 82 $385 <0.001%
28 Aug 2026 1 $5 <0.001%
27 Aug 2026 1 $5 <0.001%
25 Aug 2026 8,284 $40K 0.017%
21 Aug 2026 7,112 $33K 0.015%
19 Aug 2026 40,227 $189K 0.083%

Source: SEC fails-to-deliver (CNS) data